Black Market Sales Of Viagra In Saudi Arabia

18 May 1998

Pfizer's impotence drug Viagra (sildinafil) is selling on the blackmarket in Saudi Arabia for $53-$80 per pill, reports the Al-Eqtisadiah newspaper in Jeddah. The drug is being hand-carried from Egypt, the UK and Taiwan, it says, and some pills sold on the Saudi black market are red and yellow, indicating that they are counterfeits because the original Viagra is a blue pill.

Viagra is not yet licensed in Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Bahrain or Oman. Pharmacists in the UAE said the delay in registering it could lead to widescale smuggling. Smuggling drugs to the UAE is not new, a Dubai pharmacist told Reuters; it is a flourishing business from Arab countries and Europe where some medicines are either cheaper or sold over the counter. The business in smuggled diet and abortion pills to the UAE is big, and Viagra will soon be added to the list, he said.

If and when Pfizer applies for registration in the UAE, US Food and Drug Administration approval could speed up the process which could take up to six months, said Mariam Galadary, Saudi Arabia's director of pharmacy and drug control.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight